Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The Use of Rhythmic Light Therapy in Mild Cognitive Impairment

NCT: NCT07318038 · COMPLETED

NCT IDNCT07318038
StatusCOMPLETED
Start Date2025-12-08
Completion2026-03-31
SponsorIcahn School of Medicine at Mount Sinai (OTHER)
First posted
Last updated

Brief Summary

In this within-subjects, crossover study, participants will undergo Electroencephalogram (EEG) recordings before, during, and after each of three 1-hour sessions. All participants will experience all three conditions: (1) dual-frequency visual (10 and 40 Hz), (2) single-frequency visual (40 Hz), and (3) non-rhythmic stimulation. EEG spectral power and amplitude coupling will be analyzed to determine whether stimulation-induced increases in alpha-gamma neural synchrony translate to improvements in cognitive performance.

Frequently Asked Questions

What is The Use of Rhythmic Light Therapy in Mild Cognitive Impairment?

The Use of Rhythmic Light Therapy in Mild Cognitive Impairment is a clinical trial registered under NCT07318038. Current status: COMPLETED.

What is the status of NCT07318038?

The current status of NCT07318038 (The Use of Rhythmic Light Therapy in Mild Cognitive Impairment) is: COMPLETED.

When did The Use of Rhythmic Light Therapy in Mild Cognitive Impairment start?

The Use of Rhythmic Light Therapy in Mild Cognitive Impairment started on 2025-12-08.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.